31 Einträge gefunden

1. Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3

   1. Reich, K
   2. Iversen, L
   3. Puig, L
   4. Lambert, J
   5. Mrowietz, U
   6. Kaplan Saday, K
   7. Warren, R B

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. A Structured Intervention for Medical Students Significantly Improves Awareness of Stigmatisation in Visible Chronic Skin Diseases

   1. Sommer, Rachel
   2. Weinberger, Natascha-Alexandra
   3. von Spreckelsen, Regina
   4. Mrowietz, U
   5. Schielein, Maximilian Christian
   6. Luck-Sikorski, Claudia
   7. Augustin, Matthias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Was ist eine menschenorientierte Versorgung und warum ist sie so wichtig?

   1. Sommer, Rachel
   2. Augustin, Matthias
   3. Mrowietz, U

   2022 - Forschungsinformationssystem des UKE
4. Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany

   1. Zander, N
   2. Naatz, M
   3. Augustin, M
   4. Langenbruch, A
   5. Topp, J
   6. Mrowietz, U
   7. von Kiedrowski, R

   2021 - Forschungsinformationssystem des UKE
5. Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method

   1. Mrowietz, U
   2. Warren, R B
   3. Leonardi, C L
   4. Saure, D
   5. Petto, H
   6. Hartz, S
   7. Dossenbach, M

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

   1. Augustin, M
   2. Dauden, E
   3. Mrowietz, U
   4. Konstantinou, M P
   5. Gerdes, S
   6. Kingo, K
   7. Szepietowski, J C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis

   1. Reich, K
   2. Mrowietz, U
   3. Menter, A
   4. Griffiths, C E M
   5. Bagel, J
   6. Strober, B
   7. Nunez Gomez, N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

   1. Leutz, A
   2. Pinter, A
   3. Thaçi, D
   4. Augustin, M
   5. Schuster, C
   6. Fotiou, K
   7. Hundemer, H P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
9. Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals

   1. Diel, R
   2. Schaberg, T
   3. Nienhaus, A
   4. Otto-Knapp, R
   5. Kneitz, C
   6. Krause, A
   7. Fabri, M

   2021 - Forschungsinformationssystem des UKE
10. Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study

    1. Reich, K
    2. Körber, A
    3. Mrowietz, U
    4. Sticherling, M
    5. Sieder, C
    6. Früh, J
    7. Bachhuber, T

    2021 - Forschungsinformationssystem des UKE
11. Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study

    1. Reich, K
    2. Sullivan, J
    3. Arenberger, P
    4. Jazayeri, S
    5. Mrowietz, U
    6. Augustin, M
    7. Elewski, B

    2021 - Forschungsinformationssystem des UKE
12. Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study

    1. Maul, J-T
    2. Augustin, M
    3. Sorbe, C
    4. Conrad, C
    5. Anzengruber, F
    6. Mrowietz, U
    7. Reich, K

    2021 - Forschungsinformationssystem des UKE
13. A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

    1. Pinter, A
    2. Hoffmann, M
    3. Reich, K
    4. Augustin, M
    5. Kaplan, K
    6. Gudjónsdóttir, S D
    7. Delvin, T

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
14. A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment

    1. Reich, K
    2. Augustin, M
    3. Thaçi, D
    4. Pinter, A
    5. Leutz, A
    6. Henneges, C
    7. Schneider, E

    2020 - Forschungsinformationssystem des UKE
15. Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population

    1. Augustin, M
    2. Dauden, E
    3. Mrowietz, U
    4. Konstantinou, M P
    5. Gerdes, S
    6. Rissler, M
    7. Gathmann, S

    2020 - Forschungsinformationssystem des UKE
16. Perception and determinants of stigmatization of people with psoriasis in the German population

    1. Sommer, R
    2. Topp, J
    3. Mrowietz, U
    4. Zander, N
    5. Augustin, M

    2020 - Forschungsinformationssystem des UKE
17. Continued treatment with secukinumab is associated with high retention or regain of response

    1. Augustin, M
    2. Thaci, D
    3. Eyerich, K
    4. Pinter, A
    5. Radtke, M
    6. Lauffer, F
    7. Mrowietz, U

    2020 - Forschungsinformationssystem des UKE
18. Strategies to reduce stigma related to visible chronic skin diseases: a systematic review

    1. Topp, J
    2. Andrees, V
    3. Weinberger, N A
    4. Schäfer, I
    5. Sommer, R
    6. Mrowietz, U
    7. Luck-Sikorski, C

    2019 - Forschungsinformationssystem des UKE
19. Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases

    1. Augustin, M
    2. Mrowietz, U
    3. Luck-Sikorski, C
    4. von Kiedrowski, R
    5. Schlette, S
    6. Radtke, M A
    7. John, S M

    2019 - Forschungsinformationssystem des UKE
20. Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice

    1. Maul, J-T
    2. Navarini, A A
    3. Sommer, R
    4. Anzengruber, F
    5. Sorbe, C
    6. Mrowietz, U
    7. Drach, M

    2019 - Forschungsinformationssystem des UKE